Kevin Currie

1.6k citations
10 papers · 755 indexed · h-index 8
Topics
Monoclonal and Polyclonal Antibodies Research (5 papers)Mast cells and histamine (3 papers)Chronic Lymphocytic Leukemia Research (3 papers)
Partner nations
United States

In The Last Decade

Kevin Currie

9 papers receiving 738 citations

Peers

Kevin Currie
Comparison fields: 5 of 77
  • Organic Chemistry 460
  • Molecular Biology 259
  • Immunology 87
  • Genetics 85
  • Pharmacology 72
Replace Brad O. Buckman with:
Brad O. Buckman United States
Xavier Billot Canada
Matthew Labenski United States
Wen‐Hsing Lin Taiwan
Vanessa Desplat France
Darin E. Jones United States
Carl Crysler United States
Neelu Kaila United States
Peter D. Gorycki United States
Chris Dockendorff United States
Kevin Currie relative to Brad O. Buckman United States Brad O. Buckman's profile →
Citations per field
00.5×3.1×
Brad O. Buckman · 1×
Citations per year

Countries citing papers authored by Kevin Currie

Since Specialization
Citations

This map shows the geographic impact of Kevin Currie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Currie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Currie more than expected).

Fields of papers citing papers by Kevin Currie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Currie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Currie. The network helps show where Kevin Currie may publish in the future.

Co-authorship network of co-authors of Kevin Currie

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Currie. A scholar is included among the top collaborators of Kevin Currie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Currie. Kevin Currie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 10
2 12
3 10
4 1
5 131
6 55
7 28
8 2
9 495
10 11

About Kevin Currie

Kevin Currie is a scholar working on Genetics, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 755 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Mast cells and histamine (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Organic Chemistry (460 citations), Genetics (85 citations) and Toxicology (23 citations). Kevin Currie has collaborated with scholars based in United States. Frequent co-authors include James W. Darrow, Robert Desimone, Douglas A. Pippin, Scott A. Mitchell, Patrícia Maciejewski, Julie A. Di Paolo, Jeffrey E. Kropf, Peter Blomgren, J. Andrew Whitney and Zhongdong Zhao. Their work appears in journals such as Journal of Medicinal Chemistry, Annals of the Rheumatic Diseases and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026